Curis(CRIS)
Search documents
Curis(CRIS) - 2020 Q1 - Earnings Call Transcript
2020-05-13 00:01
Curis, Inc. (NASDAQ:CRIS) Q1 2020 Earnings Conference Call May 12, 2020 4:30 PM ET Company Participants Bill Steinkrauss - Chief Financial Officer Jim Dentzer - President & Chief Executive Officer Conference Call Participants Operator Good afternoon everyone, and welcome to Curis' First Quarter 2020 Earnings Call. All participants will be in a listen-only mode. [Operator Instructions] After the company’s prepared remarks, all participants will have an opportunity to ask questions. [Operator Instructions] Pl ...
Curis(CRIS) - 2020 Q1 - Quarterly Report
2020-05-12 20:15
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-30347 CURIS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3505116 (State or Othe ...
Curis (CRIS) Presents At 19th Annual Needham Healthcare Conference - Slideshow
2020-04-15 17:46
Corporate Presentation NASDAQ: CRIS Cautionary Note Regarding Forward Looking Statements This presentation contains certain forward-looking statements about Curis, Inc. ("we," "us," or the "Company") within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as "expect(s)," "believe(s)," "will," "may," "anticipate(s)," "focus(es)," "plans," "mission," "strategy," "potential," "estimate(s)", "intend," "project," "seek," "should," "would" and similar expressions are int ...
Curis(CRIS) - 2019 Q4 - Earnings Call Transcript
2020-03-19 23:33
Curis, Inc. (NASDAQ:CRIS) Q4 2019 Earnings Conference Call March 19, 2020 4:30 PM ET Company Participants Bill Steinkrauss - CFO James Dentzer - President and CEO Robert Martell - Head, R&D Conference Call Participants Soumit Roy - JonesTrading A.J. Rashid - Columbia Threadneedle Operator Good afternoon and welcome to the Curis Fourth Quarter and Year End 2019 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask ...
Curis(CRIS) - 2019 Q4 - Annual Report
2020-03-19 20:28
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________ FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 000-30347 CURIS, INC. (Exact Name of Registrant as Specified in Its Charter) DELAWARE 04-3505116 (State or other jurisdiction of incorpora ...
Curis(CRIS) - 2019 Q3 - Earnings Call Transcript
2019-11-05 23:36
Curis, Inc. (NASDAQ:CRIS) Q3 2019 Results Earnings Conference Call November 5, 2019 4:30 PM ET Company Participants Bill Steinkrauss - Chief Financial Officer James Dentzer - President and Chief Executive Officer Robert Martell - Research & Development Conference Call Participants Operator Good afternoon, and welcome to the Curis Third Quarter Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Opera ...
Curis(CRIS) - 2019 Q3 - Earnings Call Presentation
2019-11-05 20:38
| --- | --- | --- | |------------------------|--------------------|-------| | | | | | Corporate Presentation | CURIS NASDAQ: CRIS | 6 | Forward Looking Statements This presentation contains certain forward-looking statements about Curis, Inc. ("we," "us," or the "Company") within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as "expect(s)," "believe(s)," "will," "may," "anticipate(s)," "focus(es)," "plans," "mission," "strategy," "potential," and similar express ...
Curis(CRIS) - 2019 Q3 - Quarterly Report
2019-11-05 12:37
Table of Contents Title of each class Trading Symbol Name of each exchange on which registered Common Stock, Par Value $0.01 per share CRIS Nasdaq Global Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition perio ...
Curis (CRIS) Presents At Cantor Healthcare Conference - Slideshow
2019-10-03 18:08
| --- | --- | --- | |------------------------|--------------------|-------| | | | | | Corporate Presentation | CURIS NASDAQ: CRIS | 6 | Forward Looking Statements This presentation contains certain forward-looking statements about Curis, Inc. ("we," "us," or the "Company") within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as "expect(s)," "believe(s)," "will," "may," "anticipate(s)," "focus(es)," "plans," "mission," "strategy," "potential," and similar express ...
Curis(CRIS) - 2019 Q2 - Quarterly Report
2019-08-09 12:15
Table of Contents Title of each class Trading Symbol Name of each exchange on which registered Common Stock, Par Value $0.01 per share CRIS Nasdaq Global Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro ...